SOMAÍ is a leading EU-GMP European vertically integrated Multi-Country Operator (MCO) company with a global footprint of distribution for the largest and most advanced EU GMP-certified cannabinoid-containing pharmaceutical extract portfolio.
At SOMAÍ, we are building a leading global brand with the most robust pipeline of innovative cannabis-based therapeutics. We envision a world where people live a healthy lifestyle empowered by natural cannabis medicine.
SOMAÍ owns a state-of-the-art manufacturing facility and indoor cultivation in Lisbon, Portugal, and has global sales teams in the largest medical cannabis markets. We are continuing to make acquisitions and global brand partnerships that make us one of a few and the first European-based vertically integrated companies in the EU able to cater to the diverse needs of fast-growing global cannabis markets.
Company Details
- Employees
- 65
- Founded
- -
- Address
- Lisbon, Pt
- he****@****arma.eu
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- somaipharma.eu
- Keywords
- cannabis, investment, cultivation, partnerships, canibinoids, science, extraction, medicalcannabis, THC, biotech, healthcare.
- HQ
- Lisbon
Somaí Questions
Somaí's website is somaipharma.eu
Somaí's LinkedIn profile is https://pt.linkedin.com/company/somaipharma
Somaí has
65 employees.
View email and phone details for 65
employees at Somaí.
Somaí's industry is
Pharmaceutical Manufacturing
Somaí's top competitors are
Grupo Medinfar,
Laboratórios Atral, S.a.,
Portocanna,
Greatsoul,
Kannabeira,
Ahara,
Generis Farmacêutica,
Tilray Brands, Inc.,
Cannprisma Enhanced Medical Cannabis,
Cannamedical Pharma.
Somaí's support email address is hello@somaipharma.eu
Somaí's categories are Pharmaceutical Manufacturing
Somaí's founding year is 2019
